Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Exploring the value of ChatGPT in selecting antidiabetic agents for type 2 diabetes
Exploring the value of ChatGPT in selecting antidiabetic agents for type 2 diabetes
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Seol A. Jang
,
Su Jin Kwon
,
Chul Sik Kim
,
Seok Won Park
,
Kyoung Min Kim
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Diabetes, Obesity and Metabolism
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Impact of caloric restriction on diabetes remission in Korean adults with obesity (CREDO‐K study)
by: Mee Kyoung Kim, et al.
Published: (2025)
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multicenter trial
by: So Ra Kim, et al.
Published: (2026)
Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
by: Kyung Ah Han, et al.
Published: (2024)
Accuracy of ChatGPT , Gemini, Claude and DeepSeek in Carbohydrate Counting
by: Luca Zagaroli, et al.
Published: (2026)
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
by: Soo Lim, et al.
Published: (2024)